Renalytix (RNLXY) Earnings Date & Reports

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNLXY is expected to report earnings to fall 40.00% to -2 cents per share on November 04

Q2'25

Est.

$-0.03

Q4'24

Missed

by $0.02

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.03

The last earnings report on March 18 showed earnings per share of -5 cents, missing the estimate of -2 cents. With 49.47K shares outstanding, the current market capitalization sits at 33.40M.

View a ticker or compare two or three

Compare

RNLXY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RNLXY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNLXY showed earnings on March 18, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry ServicestotheHealthIndustry

Profile

Fundamentals

Details